GBA1 and Parkinson disease: Widespread deficiency of GCase activity has been demonstrated in the brains of PD patients carrying GBA mutations, but it is also significant that PD patients without GBA mutations were shown to exhibit deficiency of GCase in the substantia nigra (SN) as well as in blood13,14.